These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1710076)
1. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules. Ballas M; Eiermann TH; Wölpl A; Goldmann SF Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody to a supertypic determinant associated with HLA-DRw52. Eiermann TH; Krause S; Wölpl A; Ballas M; Goldmann SF Hybridoma; 1989 Aug; 8(4):467-74. PubMed ID: 2476377 [TBL] [Abstract][Full Text] [Related]
3. Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones. Irlé C; Jaques D; Tiercy JM; Fuggle SV; Gorski J; Termijtelen A; Jeannet M; Mach B J Exp Med; 1988 Mar; 167(3):853-72. PubMed ID: 2450955 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution. Bontrop RE; Elferink DG; Otting N; Jonker M; de Vries RR J Exp Med; 1990 Jul; 172(1):53-9. PubMed ID: 1694228 [TBL] [Abstract][Full Text] [Related]
5. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies. Karr RW; Lipman LK; Alber C; Koning F; Goeken NE J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807 [TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells. Madrigal JA; Ikeda H; Marsh SG; Heyes JM; Kennedy LJ; Trowsdale J; Bodmer JG J Immunol; 1989 Dec; 143(12):4084-9. PubMed ID: 2480386 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody definition of the DRB3 allele, HLA-Dw25. Fuggle SV; Carter C; Morris PJ Tissue Antigens; 1989 Sep; 34(3):149-57. PubMed ID: 2480656 [TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. Karp DR; Long EO J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684 [TBL] [Abstract][Full Text] [Related]
9. Functional polymorphism of the HLA-DR beta III chain. Sheehy MJ; Rowe JR; Koning F; Jorgensen L Hum Immunol; 1988 Jan; 21(1):49-61. PubMed ID: 2452815 [TBL] [Abstract][Full Text] [Related]
10. Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1. Löffler D; Welschof M; Goldmann SF; Wölpl A Eur J Immunogenet; 1998 Oct; 25(5):339-47. PubMed ID: 9805656 [TBL] [Abstract][Full Text] [Related]
11. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes. Klohe E; Fu XT; Ballas M; Karr RW Hum Immunol; 1993 May; 37(1):51-8. PubMed ID: 7690741 [TBL] [Abstract][Full Text] [Related]
12. A supertypic HLA class II determinant shared by DR1 and DRw9, and crossreactive with DR2, defined by human monoclonal antibody. Kosinski S; Yang SY; Pistillo MP; Hämmerling U Hum Immunol; 1988 Mar; 21(3):221-31. PubMed ID: 2453492 [TBL] [Abstract][Full Text] [Related]
13. Molecular localization of LB-Q1, a DRw52-like T-cell recognition epitope and identification at the genomic level of associated shared hybridizing fragments. Termijtelen A; Tilanus MG; Engelen I; Koning F; van Rood JJ Hum Immunol; 1987 Aug; 19(4):255-67. PubMed ID: 2445714 [TBL] [Abstract][Full Text] [Related]
14. Diversity in the fine specificity and idiotypic profile of mouse anti-HLA-DR monoclonal antibody elicited with the syngeneic anti-idiotypic monoclonal antibody F5-830. Mariani SM; Armandola EA; Ferrone S J Immunol; 1991 Aug; 147(4):1322-30. PubMed ID: 1714480 [TBL] [Abstract][Full Text] [Related]
15. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
17. A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57). Jonsson AK; Andersson L; Rask L Immunogenetics; 1989; 29(5):308-16. PubMed ID: 2497068 [TBL] [Abstract][Full Text] [Related]
18. Divergent and invariant HLA class II beta chain isoelectric points. Bontrop R; van Miltenburg R; Koning F; Gerrets R; Hyland C; Giphart M Hum Immunol; 1986 May; 16(1):38-51. PubMed ID: 2423486 [TBL] [Abstract][Full Text] [Related]
19. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity. Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528 [TBL] [Abstract][Full Text] [Related]
20. Production of two human hybridomas secreting antibodies to HLA-DRw11 and--DRw8+w12 specificities. Pistillo MP; Mazzoleni O; Kun L; Falco M; Tazzari PL; Ferrara GB Hum Immunol; 1991 Jun; 31(2):86-93. PubMed ID: 1712351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]